Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 93%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,861
Total Claims
$1.7M
Drug Cost
215
Beneficiaries
$7,885
Cost/Patient
Risk Score Breakdown 39/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+52%
Opioid rate vs peers
3.4% vs 2.2% avg
+459%
Cost per patient vs peers
$7,885 vs $1,411 avg
+88%
Brand preference vs peers
20.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.4%
Opioid Rate
336
Opioid Claims
$32K
Opioid Cost
34.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,959 claims · $1.3M
Generic: 7,819 claims · $437K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 178 | $163K |
| Valbenazine Tosylate | 12 | $96K |
| Apixaban | 223 | $95K |
| Empagliflozin | 128 | $71K |
| Fluticasone/Umeclidin/Vilanter | 106 | $69K |
| Mirabegron | 145 | $48K |
| Rifaximin | 16 | $44K |
| Paliperidone Palmitate | 19 | $36K |
| Atorvastatin Calcium | 500 | $26K |
| Oxycodone Hcl | 82 | $24K |
| Rivaroxaban | 63 | $22K |
| Lipase/Protease/Amylase | 23 | $22K |
| Duloxetine Hcl | 185 | $21K |
| Cariprazine Hcl | 15 | $19K |
| Semaglutide | 20 | $19K |
Prescribing Profile
Patient Profile
77
Avg Age
64%
Female
2.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About